Dec. 18, 2018 Price forecast | 2 weeks: 5.06% | 1 month: 5.70% | 3 months: 7.99%


DYSL stock forecast

Our latest prediction for Dynasil Corp. of America's stock price was made on the Dec. 18, 2018 when the stock price was at 0.76$.

In the short term (2weeks), DYSL's stock price should outperform the market by 5.06%. During that period the price should oscillate between -6.58% and +15.84%.

In the medium term (3months), DYSL's stock price should outperform the market by 7.99%. During that period the price should oscillate between -12.56% and +43.64%.


About Dynasil Corp. of America

Dynasil Corp. of America develops manufactures and markets detection, sensing, and analysis technology products for the homeland security, medical and industrial markets. It operates through the following three segments: Optics, Innovation & Development and Biomedical. The Optics segment encompasses four business units - Dynasil Fused Silica, Evaporated Metal Films, Hilger Crystals which manufactures commercial products, including optical crystals for sensing in the security and medical imaging markets, as well as optical components, optical coatings and optical materials for scientific instrumentation and other applications. The Biomedical segment consists of a single business unit, Dynasil Biomedical Corporation a medical technology incubator which owns rights to certain early stage medical technologies. The Innovation & Development segment consists of the Radiation Monitoring Devices, Inc. business unit, which is among the largest small business participants in the U.S. government-funded research. The company was founded in October 20, 1960 and is headquartered in Newton, MA.

At the moment the company generates 41M USD in revenues.

On its last earning announcement, the company reported a profit of 0.10$ per share.

The book value per share is 1.15$

Dynasil Corp. of America website


Three months stock forecastDec. 18, 2018


Financials

Revenue USD Gross Margin Operating Income Operating Margin Net Income Earnings Per Share Dividends Payout Ratio Shares Book Value Per Share Operating Cash Flow Cap Spending Free Cash Flow
41M 37.50% - 0.80% 2M 0.10 - - 17M 1.15 2M -2M -